Conclusions anti VEGF may provide a new approach to the treatment of gastric cancer by inhibiting tumor angiogenesis, and combination of anti VEGF antibody with MMC could be more effective.
结论通过抗vegf抑制血管形成，可能为胃癌的治疗提供一个新的途经，抗vegf抗体与MMC的联合使用将更为有效。
Vascular endothelial growth factor (VEGF) and its receptor play a critical role in tumor-associated angiogenesis and have become the new targets of anti-tumor therapy.
血管内皮细胞生长因子(VEGF)及其受体在肿瘤血管新生中起重要作用，阻断VEGF的生成已成为抗肿瘤治疗的新靶点。
Vascular endothelial growth factor (VEGF) and its receptor play a critical role in tumor associated angiogenesis and has become the new targets of anti tumor therapy.
血管内皮细胞生长因子及其受体在肿瘤新生血管形成中起重要作用，成为肿瘤治疗的新靶点。
Purpose To study the angiogenesis induced by OS 732 cell line and its inhibition by anti VEGF antibody.
目的：研究人骨肉瘤OS 732细胞系促血管生成作用及血管内皮生长因子（VEGF）抗体对其血管生成的抑制作用。
ConclusionCD105 may be used as a new marker of neovascularization in the research and treatment of anti-tumor angiogenesis.
结论CD 105可以作为新生血管的标记物用于抗肿瘤血管形成的研究和治疗。
It has been a "hot spot" about VEGF in the role of the growth and development of human brain tumor and in the therapy study about anti-tumor angiogenesis.
有关VEGF在人脑肿瘤发生、演进中的作用以及抗肿瘤血管治疗的研究成为热点。
This thesis gives a review on tumor angiogenesis, the features of VEGF family, the application of VEGF on anti - tumor drugs.
本文就肿瘤血管生成、VEGF家族的特性、VEGF在抗肿瘤药物开发中的应用做一综述。
Inhibited tumor Angiogenesis and Inhibited tumor cell's invasion, adhesion, motor abilities could be important mechanisms of QRXJR in anti-metastasis.
抑制肿瘤血管生成和抑制肿瘤细胞的侵袭和黏附、运动能力等可能是该方抗肿瘤转移的重要机制之一。
As potential anti tumor agents, a list of angiogenesis inhibitors are currently undergoing clinical and pre clinical study.
一批新生血管抑制物正处于临床或临床前试验的研究阶段。
HA plays an important role in debridement, anti-inflammatory, promoting wound healing. Its metabolites can promote angiogenesis, proliferation of fibroblasts, modulate the synthesis of collagen.
透明质酸盐在创面修复过程中具有清创、抗炎、促进创伤愈合重要作用，其代谢产物能够促进血管生成及成纤维细胞增殖，调控胶原合成。
AIM: To evaluate the security of an anti-tumor angiogenesis complex peptide vaccine VBP3.
目的：评价抑制肿瘤血管新生的复合肽VBP3的安全性。
CONCLUSION: the complex peptide vaccine VBP3 for anti-tumor angiogenesis is safe under the experimental conditions.
结论：抑制肿瘤血管新生的复合肽VBP3在本实验条件下安全。
CONCLUSION: the complex peptide vaccine VBP3 for anti-tumor angiogenesis is safe under the experimental conditions.
结论：抑制肿瘤血管新生的复合肽VBP3在本实验条件下安全。
应用推荐